Avalo Therapeutics Inc (AVTX-Q) Analyst Research & Price Targets - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Current Target Price

High Target Price

Mean Target Price

Low Target Price

Median Target Price

Earnings Estimates

	Current Qtr06/2024	Next Qtr09/2024	Fiscal Yr12/2024	Fiscal Yr12/2025
Average Estimate	-0.19	-0.36	-0.91	-0.97
Number of Estimates	1	1	1	1
High Estimate	-0.19	-0.36	-0.91	-0.97
Low Estimate	-0.19	-0.36	-0.91	-0.97
Prior Year	-140.48	-26.19	-114.00	-0.91
Growth Rate Est. (year over year)	+99.86%	+98.63%	+99.20%	-6.59%

Earnings History - Surprises*

	Qtr Ending03/2024	Qtr Ending12/2023	Qtr Ending09/2023	Qtr Ending06/2023
Reported	$-5.98	N/A	$-26.19	$-140.48
Estimate	$-1.18	N/A	$-261.90	$-214.29
Difference	-4.80	N/A	+235.71	+73.81
Surprise	-406.78%	N/A	+90.00%	+34.44%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

3.00

3 Mths Ago1

3.00

2 Mths Ago1

3.00

1 Mth Ago1

5.00

Current1

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	1	1	1	1
				1
Holds	1	1	1	0

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

The close: Wall Street boasts fresh records as inflation data fuels rate-cut bets

Chevron tops Tesla as most-shorted stock in April, says Hazeltree

The close: Nasdaq at record high after Fed chair’s comments but TSX dips for third day

The close: S&P 500, TSX slip as investors await inflation data; meme rally reignites

Shopify executive earned US$76-million in 2023, far outpacing CEO’s compensation

Advantage Energy director buys as stock rallies

The close: S&P 500 higher but TSX slips as traders await key U.S. inflation data

You’ve heard of dollar-cost averaging. How about trying dollar-cost selling?